Benefit of targeted intensification for NCI high risk childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council trial ALL97 and ALL97/99.

Παρόμοια τεκμήρια

• The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
  ανά: Mitchell, C, κ.ά.
  Έκδοση: (2009)
• Variables affecting kinetics of minimal residual disease clearance in children with lymphoblastic leukaemia; Results of the United Kingdom Medical Research Council (UK MRC) protocols ALL97, ALL97/99 and ALL2003.
  ανά: Vora, A, κ.ά.
  Έκδοση: (2005)
• Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
  ανά: Lennard, L, κ.ά.
  Έκδοση: (2005)
• Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
  ανά: Mitchell, C, κ.ά.
  Έκδοση: (2005)
• Thioguanine-related veno-occlusive disease (VOD) of the liver in children with acute lymphoblastic leukaemia (ALL): Report from United Kingdom Medical Research Council (UK MRC) trial ALL97.
  ανά: Vora, A, κ.ά.
  Έκδοση: (2002)